Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN · NASDAQ Global Select
-$5.45 today
Vol 2.04M · Avg 0.91M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+19.80%
Period High
$810.09
Period Low
$509.14
Latest
$609.94
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Elevance Health Inc.
NYSE:ELV
$84.08B
Cigna Corporation
NYSE:CI
$74.10B
argenx SE
NASDAQ:ARGX
$54.43B
Cencora, Inc.
NYSE:COR
$52.62B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.03B
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
$36.95B
Zoetis Inc.
NYSE:ZTS
$32.88B
United Therapeutics Corporation
NASDAQ:UTHR
$22.96B
Incyte Corporation
NASDAQ:INCY
$19.42B
Genmab A/S
NASDAQ:GMAB
$15.55B
What is the latest REGN filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does REGN have?
Intrinsic Alpha currently shows 20 recent filings for REGN.
Explore More
Continue the stock analysis
Jump to another research area for this company.